Kyverna Therapeutics, Inc.
(KYTX - NASDAQ)
8,99 USD
📋 Profilo Aziendale

Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients suffering from autoimmune diseases.

|